Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Sangamo and Schering AG enter research agreement for Universal GeneTools technology

Aug. 26, 1999

Study commences of pulmonary delivery of migraine therapy

Aug. 23, 1999

Stem Cell Sciences and Rhone-Poulenc Rorer enter agreement

Aug. 23, 1999

ImmGenics' SLAM technology presented at conference

Aug. 20, 1999

Medi-Ject proceeds with development of needle-free device for male impotence therapy

Aug. 18, 1999

CAT and HGS enter agreement for therapeutic antibody development

Aug. 17, 1999

Argent gene delivery platform used successfully for sustained, controlled delivery of hGH

Aug. 16, 1999

Creative BioMolecules, NeoGenesis team up to identify new drugs to treat degenerative disorders

Aug. 16, 1999

Immune Complex Corporation awarded SBIR contract to detect cytochrome P450 polymorphisms

Aug. 16, 1999

Aastrom Biosciences enters distribution agreements for Norway and Switzerland

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...